SQ Innovation today announced that results of the SUBCUT HF II trial of its product Lasix® ONYU, will be presented at Heart Failure 2026, the annual congress of the Heart Failure Association (HFA) of ...
Total hip arthroplasty leads to the best outcomes in the treatment of moderate-to-severe hip osteoarthritis, according to a ...
Eating a plant-based diet may help reduce levels of a key inflammation marker in the body, according to new research from the ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
A postbiotic reduced allergic rhinitis symptoms in a clinical trial. Could microbiome therapies transform treatment? Read ...
Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...
MedPage Today on MSN
Game-Changer? Wegovy Cuts Heavy Drinking in Alcohol Addiction Trial
Findings come amid growing off-label prescribing of GLP-1 drugs for addiction ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results